Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapy

Publisher Website
Google Scholar
Abstract
Nineteen patients in continuous complete remission of acute leukemia for at least 1 yr received late intensification therapy, after which they received no further chemotherapy, but most received BCG immunotherapy. Five patients relapsed. The 14 patients still in remission were followed up for at least 60 wk after late intensification, with a median time of 98 wk. The length of complete remission subsequent to a comparable time was 44 wk for a reference control group and 24 wk for a matched control group. These results support this type of approach for long-term control of acute leukemia in adults.

This publication has 2 references indexed in Scilit: